On October 10, 2022 Kineta, Inc. ("Kineta" or the "Company"), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology, reported that the Company’s management team will participate in the following investor conferences in October 2022 (Press release, Yumanity Therapeutics, OCT 10, 2022, View Source [SID1234621901]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Needham Virtual Biotech Private Company 1×1 Forum

Opal Group Family Office & Private Wealth Management Forum West